InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Tan Kevin, Chief Financial Officer. Insider active across 1 company, notably Selecta Biosciences INC. In total, 4 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €27k. Activity tracked since 2 December 2021. The latest transaction was disclosed on 3 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
72,000 shares0Common StockSEC:0001453687-22-000024
72,000 shares0Common StockSEC:0001453687-22-000024:0
5,000 shares@ US$3.0253100.0% of flowCommon StockSEC:0001453687-21-000164
Ideal exit: 29 Aug 2022 (T+270)
5,000 shares@ US$3.025350.0% of flowCommon StockSEC:0001453687-21-000164:0
Ideal exit: 29 Aug 2022 (T+270)
4 of 4 declarations
About Tan Kevin
Kevin Tan is the Chief Financial Officer of Selecta Biosciences Inc. He is responsible for the financial management of the company, including budgeting and financial reporting. His expertise in finance is essential to support the growth and sustainability of the organization.
